Tower Research Capital (TRC)’s Outset Medical OM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $35.3K | Buy |
1,837
+1,823
| +13,021% | +$35K | ﹤0.01% | 3272 |
|
|
2025
Q1 | $155 | Buy |
+14
| New | +$155 | ﹤0.01% | 5004 |
|
|
2024
Q4 | – | Sell |
-568
| Closed | -$5.77K | – | 5913 |
|
|
2024
Q3 | $5.77K | Sell |
568
-1,152
| -67% | -$11.7K | ﹤0.01% | 4225 |
|
|
2024
Q2 | $99.3K | Buy |
1,720
+824
| +92% | +$47.6K | ﹤0.01% | 2585 |
|
|
2024
Q1 | $29.8K | Buy |
896
+133
| +17% | +$4.43K | ﹤0.01% | 2653 |
|
|
2023
Q4 | $61.9K | Sell |
763
-366
| -32% | -$29.7K | ﹤0.01% | 2987 |
|
|
2023
Q3 | $184K | Buy |
1,129
+1,061
| +1,560% | +$173K | 0.01% | 1487 |
|
|
2023
Q2 | $22.2K | Buy |
68
+10
| +17% | +$3.26K | ﹤0.01% | 3271 |
|
|
2023
Q1 | $16K | Buy |
58
+40
| +222% | +$11K | ﹤0.01% | 3726 |
|
|
2022
Q4 | $7K | Sell |
18
-183
| -91% | -$71.2K | ﹤0.01% | 4595 |
|
|
2022
Q3 | $48K | Buy |
201
+56
| +39% | +$13.4K | ﹤0.01% | 3193 |
|
|
2022
Q2 | $32K | Buy |
145
+104
| +254% | +$23K | ﹤0.01% | 3307 |
|
|
2022
Q1 | $28K | Sell |
41
-18
| -31% | -$12.3K | ﹤0.01% | 3227 |
|
|
2021
Q4 | $40K | Sell |
59
-179
| -75% | -$121K | ﹤0.01% | 2948 |
|
|
2021
Q3 | $177K | Buy |
238
+172
| +261% | +$128K | ﹤0.01% | 1927 |
|
|
2021
Q2 | $49K | Sell |
66
-19
| -22% | -$14.1K | ﹤0.01% | 3043 |
|
|
2021
Q1 | $69K | Buy |
85
+13
| +18% | +$10.6K | ﹤0.01% | 2864 |
|
|
2020
Q4 | $61K | Buy |
72
+39
| +118% | +$33K | ﹤0.01% | 2901 |
|
|
2020
Q3 | $25K | Buy |
+33
| New | +$25K | ﹤0.01% | 3792 |
|